Cancer
ESMO 2025: VT3989 Demonstrates Promising Early Outcomes in Advanced Mesothelioma Patients
In a groundbreaking advancement in oncology, researchers from The University of Texas MD Anderson Cancer Center have unveiled promising results...
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
In a landmark discovery that could alter the course of cancer treatment, researchers at The University of Texas MD Anderson...
New Study Reveals COVID-19 mRNA Vaccine Triggers Immune Response That Could Combat Cancer
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs...
New Drug Combination Reduces Mortality Risk in Advanced Prostate Cancer by 40%
A groundbreaking advancement in prostate cancer treatment offers new hope to men whose disease returns after initial attempts at surgery...
Antibody-Drug Conjugates Enhance Outcomes in Advanced Triple-Negative Breast Cancer Patients Unsuitable for Immune Checkpoint Inhibitors
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial,...
ARNT2 Activates STRA6, Fueling Liposarcoma Progression
Recent research has unveiled critical insights into the biological mechanisms underlying retroperitoneal liposarcoma (RPLS), a rare and aggressive form of...
Exercise-Conditioned Serum Inhibits Prostate Cancer Growth
Recent advancements in cancer research have shed light on the intricate connections between physical activity and cancer progression. A groundbreaking...
AI-Enhanced Multimodal Care for Pancreatic Cancer
In a groundbreaking European initiative poised to redefine supportive care in oncology, the RELEVIUM project launches a multicenter randomized controlled...
Curcumin’s Role in Prostate Cancer Therapy
In the relentless battle against prostate cancer, a beacon of hope emerges from the ancient spice turmeric. A newly published...
ESMO 2025: Belzutifan Demonstrates Tumor Reduction and Symptom Relief in Patients with Rare Neuroendocrine Tumors
In a landmark advancement for the treatment of rare neuroendocrine tumors, researchers have reported groundbreaking results with the oral HIF-2α...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!